Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study
| Autor: | Rashad, Noha, Abdelhamid, Thoraya, Shouman, Samia A., Nassar, Hanan, Omran, Mervat A., El Desouky, Eman D., Khaled, Hussein |
|---|---|
| Zdroj: | In Clinical Breast Cancer June 2020 20(3):228-237 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect